10-K: THERAVANCE INC – MarketWatch (press release)
10-K: THERAVANCE INC MarketWatch (press release) In December 2008, we announced positive safety and efficacy results from the asthma study and the COPD study with '444, and in February 2009 we announced positive safety and efficacy results from three asthma studies with FF. ... |